New research from Compass Pathways says that:
“It has long been thought that SSRIs could interfere with the potential therapeutic effect of psilocybin.
This data is exciting because it provides a preliminary signal that this is not the case, and that patients could remain on their SSRI antidepressant medication and experience the same effect from COMP360 psilocybin treatment as people who are not on SSRIs.”